Biogel Indicator System
Payments companies reported to CMS as associated with Biogel Indicator System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Biogel Indicator System, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Biogel Indicator System
These are the largest totals companies reported as associated with Biogel Indicator System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Jayakar | Longview, TX | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $14,866.23 |
| Kim Stearns | Cleveland, OH | Adult Reconstructive Orthopaedic Surgery | $6,318.66 |
| Robert Sawyer | Kalamazoo, MI | Surgical Critical Care | $6,172.67 |
| Abhishek Chatterjee | Lebanon, NH | Surgery | $6,097.67 |
| Kurt Wharton | Royal Oak, MI | Obstetrics & Gynecology | $5,953.13 |
| Michel Wagner | Monroeville, PA | Surgical Critical Care | $5,387.19 |
| Joyesh Raj | Westlake, OH | Plastic Surgery | $5,188.19 |
| Salvatore Nardello | Stoneham, MA | Surgical Oncology | $451.65 |
| Andrew Dennis | Chicago, IL | Surgery | $188.21 |
| Melissa Dennis | Chicago, IL | Obstetrics & Gynecology | $188.21 |
Prescribed Biogel Indicator System?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.